AVALON MEDICAL DEVELOPMENT CORPORATION (EIN 330222508) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1987

Legal Domicile

Principal Officer

TIM KIELPINSKI

Phone

3105100700

Tax Period

2024-07-01 to 2025-06-30

AVALON MEDICAL DEVELOPMENT CORPORATION, founded in 1987, is a mid-sized nonprofit in the Health Care sector that reported $20.6M in total revenue in fiscal year 2024. Revenue grew 8% year-over-year, indicating healthy expansion. Expenses of $18.8M left a modest 9% surplus.

Mission

PROVIDE HEALTHCARE BENEFITS TO THE COMMUNITY OF CATALINA ISLAND AND MORE THAN 1 MILLION VISITORS EACH YEAR.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $4,699,489

Program Service Revenue $16,819,336

Investment Income $14,639

Other Revenue $-942,141

TOTAL REVENUE $20,591,323

Expense Breakdown

Grants Paid $0

Salaries & Benefits $9,970,763

Fundraising Expenses $0

Program Expenses $12,462,430

Other Expenses $8,817,675

TOTAL EXPENSES $18,788,438

Year-over-Year Comparison

	2024	2023	Change
Revenue	$20,591,323	$19,051,866	+0.1%
Expenses	$18,788,438	$18,950,532	0.0%
Net Income	$1,802,885	$101,334	+16.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

141

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$628,130

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
CATRINA AWALT	CHAIR	1.00	Officer Director	$0	$0	$0
NICOLE HEHENSTEIN	VICE CHAIR	1.00	Officer Director	$0	$0	$0
RENEE MACLEOD	TREASURER	1.00	Officer Director	$0	$0	$0
JUDY GREER	SECRETARY	1.00	Officer Director	$0	$0	$0
JOHN BAACKES	MEMBER	1.00	Director	$0	$0	$0
DR JOHN CHRISTIAN FOX	MEMBER	1.00	Director	$0	$0	$0
EHAB MADY	MEMBER (THRU JUL 2025)	1.00	Director	$0	$0	$0
DENISE MOTTER	MEMBER	1.00	Director	$0	$0	$0
TRUDY SALDANA	MEMBER	1.00	Director	$0	$0	$0
PETE SAVAGE	MEMBER (THRU JUL 2025)	1.00	Director	$0	$0	$0
JASON PARET	CEO	40.00	Officer	$427,880	$12,747	$440,627
ERIC CAMPBELL	CONTRACT CFO (THRU MAR 2025)	40.00	Officer	$187,503	$0	$187,503
MEGHAN ZOMORODI	PHYSICIAN	40.00	Highest	$349,097	$4,803	$353,900
PARULBEN PATEL	CLINICAL LABORATORY MANAGER	40.00	Highest	$268,795	$2,984	$271,779
NEIL MACREADY	CHIEF DEVELOPMENT OFFICER	40.00	Highest	$213,002	$5,823	$218,825
HAZEL EDQUID	CLINICAL LABORATORY SCIENTIST	40.00	Highest	$208,530	$895	$209,425
TIMOTHY KIELPINSKI	CHIEF STRATEGY OFFICER	40.00	Highest	$207,519	$0	$207,519

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$20,591,323	$18,788,438	$14,942,758	$1,802,885
2024	No data	No data	No data	No data
2023	$22,068,931	$19,255,227	$11,876,797	$2,813,704
2023	$20,951,940	$18,138,236	$11,876,797	$2,813,704
2022	$16,117,549	$15,485,336	$9,855,020	$632,213
2021	$15,228,137	$13,505,505	$9,845,818	$1,722,632

AVALON MEDICAL DEVELOPMENT CORPORATION